{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:15:30Z","timestamp":1773947730115,"version":"3.50.1"},"reference-count":33,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Governor\u2019s Grant of the Samara region, Russian Federation","award":["RF \u2116336 from 27-04-2018"],"award-info":[{"award-number":["RF \u2116336 from 27-04-2018"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>In the context of modern drug discovery, there is an obvious advantage to designing phenotypic bioassays based on human disease-relevant cells that express disease-relevant markers. The specific aim of the study was to develop a convenient and reliable method for screening compounds with Tumor Necrosis Factor-alpha (TNF-\u03b1) inhibitory activity. This assay was developed using cryopreserved ready-to-use cartilage-derived cells isolated from juvenile donors diagnosed with polydactyly. It has been demonstrated that all donor (10 donors) cells were able to respond to TNF-\u03b1 treatment by increased secretion of pro-inflammatory cytokine IL-6 into subcultural medium. Inhibition of TNF-\u03b1 using commercially available TNF-\u03b1 inhibitor etanercept resulted in a dose-dependent decrease in IL-6 production which was measured by Enzyme-Linked Immunosorbent Assay (ELISA). TNF-\u03b1 dependent IL-6 production was detected in the cells after both their prolonged cultivation in vitro (\u226520 passages) and cryopreservation. This phenotypic bioassay based on ready-to-use primary human cells was developed for detection of novel TNF-\u03b1 inhibitory compounds and profiling of biosimilar drugs.<\/jats:p>","DOI":"10.3390\/biom10111563","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T07:23:28Z","timestamp":1605597808000},"page":"1563","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rheumatoid Arthritis: Applicability of Ready-to-Use Human Cartilaginous Cells for Screening of Compounds with TNF-Alpha Inhibitory Activity"],"prefix":"10.3390","volume":"10","author":[{"given":"Larissa T.","family":"Volova","sequence":"first","affiliation":[{"name":"Institute of Experimental Medicine and Biotechnology, Samara State Medical University, Chapaevskaya St., 89, 443099 Samara, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeniy I.","family":"Pugachev","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine and Biotechnology, Samara State Medical University, Chapaevskaya St., 89, 443099 Samara, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria V.","family":"Rossinskaya","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine and Biotechnology, Samara State Medical University, Chapaevskaya St., 89, 443099 Samara, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violetta V.","family":"Boltovskaya","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine and Biotechnology, Samara State Medical University, Chapaevskaya St., 89, 443099 Samara, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry A.","family":"Dolgushkin","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine and Biotechnology, Samara State Medical University, Chapaevskaya St., 89, 443099 Samara, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0444-8174","authenticated-orcid":false,"given":"Natalya","family":"Ossina","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine and Biotechnology, Samara State Medical University, Chapaevskaya St., 89, 443099 Samara, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.trsl.2014.09.006","article-title":"Tumor necrosis factor inhibitors: Clinical utility in autoimmune diseases","volume":"165","author":"Willrich","year":"2015","journal-title":"Transl. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cytogfr.2014.07.016","article-title":"TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants\u2013past, present and future","volume":"25","author":"Sedger","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Melagraki, G., Ntougkos, E., Rinotas, V., Papaneophytou, C., Leonis, G., Mavromoustakos, T., Kontopidis, G., Douni, E., Afantitis, A., and Kollias, G. (2017). Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-\u03baB Ligand (RANKL). PLoS Comput. Biol., 13.","DOI":"10.1371\/journal.pcbi.1005372"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.bmc.2018.01.032","article-title":"Design, synthesis and biological assessment of N-adamantyl, substituted adamantyl and noradamantyl phthalimidines for nitrite, TNF-\u03b1 and angiogenesis inhibitory activities","volume":"26","author":"Luo","year":"2018","journal-title":"Bioorganic Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1089\/adt.2010.0305","article-title":"Primary Cells and Stem Cells in Drug Discovery: Emerging Tools for High-Throughput Screening","volume":"9","author":"Eglen","year":"2010","journal-title":"Assay Drug Dev. Technol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s12012-019-09532-x","article-title":"The Use of iPSC-Derived Cardiomyocytes and Optical Mapping for Erythromycin Arrhythmogenicity Testing","volume":"19","author":"Podgurskaya","year":"2019","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd.2016.175","article-title":"Screening out irrelevant cell-based models of disease","volume":"15","author":"Horvath","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_8","first-page":"110","article-title":"Bringing primary cells to mainstream drug development and drug testing","volume":"9","author":"Goldbard","year":"2006","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0022-1759(84)90147-9","article-title":"Comparison of in vitro cell cytotoxic assays for tumor necrosis factor","volume":"68","author":"Flick","year":"1984","journal-title":"J. Immunol. Methods"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1006\/cyto.1998.0492","article-title":"Modes of L929 cell death induced by TNF-\u03b1 and other cytotoxic agents","volume":"11","author":"Humphreys","year":"1999","journal-title":"Cytokine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0165-2478(95)00026-2","article-title":"WEHI-13VAR: A stable and sensitive variant of WEHI 164 clone 13 fibrosarcoma for tumor necrosis factor bioassay","volume":"46","author":"Khabar","year":"1995","journal-title":"Immunol. Lett."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-1759(86)90322-4","article-title":"A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor\/tumor necrosis factor from human monocytes","volume":"95","author":"Espevik","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4161\/mabs.12304","article-title":"Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor \u03b1","volume":"2","author":"Shealy","year":"2010","journal-title":"MAbs"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jim.2011.08.022","article-title":"Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNF\u03b1 antagonists","volume":"373","author":"Lallemand","year":"2011","journal-title":"J. Immunol. Methods"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/cyto.1995.1003","article-title":"The mouse\/human chimeric monoclonal antibody ca2 neutralizes tnf in vitro and protects transgenic mice from cachexia and tnf lethality in vivo","volume":"7","author":"Siegel","year":"1995","journal-title":"Cytokine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.biologicals.2015.03.001","article-title":"Gene expression of cultured human chondrocytes as a model for assessing neutralization efficacy of soluble TNF\u03b1 by TNF\u03b1 antagonists","volume":"43","author":"Blejec","year":"2015","journal-title":"Biologicals"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biologicals.2016.09.013","article-title":"Applicability of human osteoarthritic chondrocytes for in vitro efficacy testing of anti-TNF\u03b1 drugs","volume":"45","author":"Jeras","year":"2017","journal-title":"Biologicals"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/art.22372","article-title":"Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis","volume":"56","author":"Lories","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/eji.200939578","article-title":"Animal models of rheumatoid arthritis","volume":"39","author":"Asquith","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/ten.tec.2010.0200","article-title":"Human Primary Articular Chondrocytes, Chondroblasts-Like Cells, and Dedifferentiated Chondrocytes: Differences in Gene, MicroRNA, and Protein Expression and Phenotype","volume":"17","author":"Karlsen","year":"2010","journal-title":"Tissue Eng. Part C Methods"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/1759720X12448454","article-title":"Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis","volume":"4","author":"Goldring","year":"2012","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1089\/ten.teb.2013.0771","article-title":"Chondrogenic Differentiation of Mesenchymal Stem Cells: Challenges and Unfulfilled Expectations","volume":"20","author":"Somoza","year":"2014","journal-title":"Tissue Eng. Part B Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/art.37760","article-title":"Zone-specific gene expression patterns in articular cartilage","volume":"65","author":"Grogan","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/joca.1999.0306","article-title":"Cellular interactions and signaling in cartilage development","volume":"8","author":"DeLise","year":"2000","journal-title":"Osteoarthr. Cartil."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1242\/dev.105536","article-title":"A pathway to bone: Signaling molecules and transcription factors involved in chondrocyte development and maturation","volume":"142","author":"Kozhemyakina","year":"2015","journal-title":"Development"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/jor.22954","article-title":"Choosing the right chondrocyte cell line: Focus on nitric oxide","volume":"33","author":"Santoro","year":"2015","journal-title":"J. Orthop. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.orthres.2004.08.008","article-title":"Rapid phenotypic changes in passaged articular chondrocyte subpopulations","volume":"23","author":"Darling","year":"2005","journal-title":"J. Orthop. Res."},{"key":"ref_28","first-page":"101","article-title":"Surface markers and gene expression to characterize the differentiation of monolayer expanded human articular chondrocytes","volume":"75","author":"Hamada","year":"2013","journal-title":"Nagoya J. Med. Sci."},{"key":"ref_29","first-page":"183","article-title":"High Quality of Infant Chondrocytes in Comparison with Adult Chondrocytes for Cartilage Tissue Engineering","volume":"6","author":"Mortazavi","year":"2017","journal-title":"World J. Plast. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/jor.20523","article-title":"Gene expression profiles of human chondrocytes during passaged monolayer cultivation","volume":"26","author":"Lin","year":"2008","journal-title":"J. Orthop. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.drudis.2007.05.008","article-title":"Cryopreserved cells facilitate cell-based drug discovery","volume":"12","author":"Zaman","year":"2007","journal-title":"Drug Discov. Today"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.drudis.2007.08.014","article-title":"Evolution of cell-based reagent provision","volume":"12","author":"Cawkill","year":"2007","journal-title":"Drug Discov. Today"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Harris, D. (2018). Biobanking and Regenerative Medicine: An Overview. J. Clin. Med., 7.","DOI":"10.3390\/jcm7060131"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/10\/11\/1563\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:34:36Z","timestamp":1760178876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/10\/11\/1563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["biom10111563"],"URL":"https:\/\/doi.org\/10.3390\/biom10111563","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]}}}